NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

Correct I think this will be the tineline
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176125487
(4) Timeline from here on:
A. It is likely that NWBO received another RFI stemming from the on-site clinical trial inspections conducted by the MHRA between mid-September 2024 and the end of February 2025. Preparing that RFI and sending it to NWBO would have taken time, likely occurring around mid- to late-March 2025 — just before NWBO’s last 10-K was filed. Let's assume that NWBO will take about two months to answer this RFI. They would therefore submit their response just before ASCO (early June), which would also explain why NWBO canceled their ASCO presence and said they want to stay focused on the application.
B. After NWBO submits their response, the MHRA review clock will start running again.
If the MHRA then takes around 60 days for final review, that would put a possible decision around the end of July 2025.